These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36247875)

  • 1. Comprehensive Analysis of the Role of
    Chu M; Zheng K; Li X; Luo Z; Yang X; Wei C
    Anal Cell Pathol (Amst); 2022; 2022():2371057. PubMed ID: 36247875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma.
    Zhang Z; Ren X; Wang Y; Liu P; Lin P; Jin S; Xu C
    BMC Oral Health; 2024 Jun; 24(1):742. PubMed ID: 38937712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
    Zhang S; Yu S; Wang J; Cheng Z
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33687056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the relationship between GLUT family in the progression and immune infiltration of head and neck squamous carcinoma.
    Li B
    Diagn Pathol; 2023 Aug; 18(1):88. PubMed ID: 37542344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma.
    He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
    Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
    Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
    Jiang W; Xu S; Li P
    PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
    Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H
    BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
    Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
    Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma.
    Yang J; Song T
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):909-919. PubMed ID: 38546073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
    Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
    Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
    Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
    J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
    Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
    Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis.
    Wang J; Sun Z; Wang J; Tian Q; Huang R; Wang H; Wang X; Han F
    Cancer Med; 2021 Sep; 10(18):6515-6533. PubMed ID: 34331382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
    Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
    PeerJ; 2023; 11():e16237. PubMed ID: 37842043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.